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Summary: In a study with young children receiving growth hormone treatment, it was necessary to re-establish
reference values for various blood components, e. g. apolipoproteins A-I and B. We find that considerable method-
to-method Variation still exists. We used the DuPont Dimension analyzer (D) and the Beckman Array analyzer (B)
Systems and a third procedure with Orion reagents and a Kone Analyzer (K). We investigated if assay results may
be pooled or exchanged within our study. In 59 serum samples we measured apolipoprotein A-I and apolipoprotein
B (n = 58) and calculated the orthogonal regression equations y = a(Sa) + b(Sb).
For apolipoprotein A-I the results are:
(I) B = 1.165 (0.065) D - 0.193 (0.077), Syx = 0.055; with r = 0.922 and
(II) K = 0.831 (0.056) D - 0.190 (0.066), Syx = 0.055; with r = 0.898.
For apolipoprotein B the equations are
(III) B = 1.586 (0.137) D - 0.246 (0.100), S^ = 0.061; with r = 0.840 and
(IV) K - 0.869 (0.065) D -l· 0.251 (0.048), Syx = 0.044: with r = 0.875.
According to Passing & Bablok, the slopes and intercept values are 1.093 and -0.126; 0.848 and 0.167; 1.500 and
—0.185; 0.880 and 0.249. The overall impression is the same for both regression methods: comparability had not
yet been achieved by early 1993, particularly not for apolipoprotein B, and reference values differ significantly
depending on the selected methodology.
Introduction In parallel with a search for matrix compatible reference
. . .. materials (6), the effect of lyophilisation was also
Several reports in the literature have documented sigmf- studied (7> g) ft ^^ Qut ̂  reference semm for
icant progress with regard to improvmg the analytical apoIipOprotein A-I could be manufactured and that
reliability of apolipoprotein analysis. The lack of mter standardizing the apolipoprotein B calibration, although
laboratory comparability is notorious and still hampers it is a more difficult protein with respect to solubility,
the use of clinical chemical data severely. Activities un- ajso has come wjthin reach. Recently the results of the
dertaken at the Centers for Disease Control (CPC), At- use of a common serum calibrator for apolipoprotein
lanta, USA (G. R. Cooper et al.) (1,2) and at the North- A-I determination have been published. The succesful
west Lipid Research Laboratories in Seattle, USA (J. J. transfer of analytical accuracy was demonstrated (9).
Albers, S. M. Marcovina et al.) paved the way towards The World Health Organization (WHO) has approved
a coordinated project (3—5) with the International Fed- this material, SP1-01, äs the WHO-IFCC International
eration of Clinical Chemistry (IFCC). Reference Material for Apolipoprotein A-I.
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As a result of the IFCC project, the usual Situation of
non-comparable assay data (10) may be expected to im-
prove drastically. Very recently the succesful validation
of the WHO-IFCC International Reference Material for
Apolipoprotein B (SP3-07) was published äs well (11).
In a study on reference values of various blood lipid
fractions in young children, we analyzed the same set of
serum samples in all three cooperating laboratories.
We will eventually compare and integrate these data
with earlier studies on reference values in children.
Our long Standing interest in lipid standardization activi-
ties led us to investigate the effect upon the reference
ranges of the laboratory measurement (12, 13).
With regard to the measurement of apolipoprotein A-I
and B, we hoped the results of at least two of our meth-
ods would be comparable, because the manufacturers of
the reagents and calibrators (DuPont de Nemours (Ne-
derland) BV and Beckman Instruments Nederland BV)
had previously indicated to us that their assay Systems
could be considered "standardized" (apolipoprotein A-I
äs well äs apolipoprotein B) äs a result of their coopera-
tion in the IFCC International Standardization of the im-
munochemical determination of apolipoprotein A-I and
B. Beckman Instruments Inc. circulated a notification to
this effect äs early äs June 10, 1991 (14). At the time
we carried out our measurements no such Information
had been obtained from the third manufacturer (Orion).
Materials and Methods
Patients' blood samples
The study was approved by the Ethics Committee of the Rotterdam
University Hospital and written informed consent was obtained
from the parents of 59 healthy children aged 1.9-9.9 years, who
came to the Sophia Childrens Hospital for minor surgery, e. g. a
circumcision of the penis or excision of the tonsils. Children with
any disorders involving lipid metabolism wefe excluded. Venous
blood was collected in the fasting state immediately after the anaes-
thetics were given.
The blood was centrifuged after allowing to clot for an hour. The
serum was collected, fresh-frozen and stored at -75 °C for a
period of a few months. At the end of the collection period lipid
and apolipoprotein determinations were earried out within a few
hours after thawing the serum aliquots. These sera were analysed
using all 3 methods in the same week.
Apolipoprotein determinations
Apolipoprotein A-I and B were measured by thfee different meth-
ods:
Immuno-nephelometry
In the immuno-nephelometric, kinetic technique of the University
Hospital (for adults) Dijkzigt, we used the Array Protein System
(Beckman Instruments Co, Brea, CA 92621-6209, USA). Antibod-
ies raised against specific human apolipoproteins are brought into
contact with the serum sample (40 ). The antigen-antibody reac-
tion gives rise to aggregates that scatter light The peak rate signal
of light scattering is converted to cpncentration units on the basis
of calibration with Apolipoprotein Calibrator "Apolipoprotein
Cal".
This single point procedure verifies, and if necessary corrects, the
Position of a pre-programmed standar$lfcurve. The product Infor-
mation sheet indicates that the calibration is traceable to "the pro-
posed WHO International Reference Materials for Apolipoprotein
A-I". The product Information about the apolipoprotein B calibra-
tion makes no mention of calibratipn material.
Method precision with lyophilized commercial quality controls:
Between-run CV, week-to-week during 23 consecutive weeks in
the flrst half of 1993, for apolipoprotein A-I (at 1.23 g/l) is 4.2%
and for apolipoprotein B (at 1.16 g/l) is 3.8%.
Turbidimetry (Dimension)
In the turbidimetric imrnuno-assay of the Sophia Childrens Univer-
sity Hospital we used the Dimension Analyser (DuPont Medical,
Wilmington, Delaware, USA). Antibodies raised against human
apolipoproteins are brought into contact with the serum sample
(2 ). The resulting imimme-complexes give rise to turbidity in
the assay cuvette. Photometric extinction readings are converted
into concentrations on the basis of calibration with DuPont Apoli-
poprotein Calibrators. A five-point Standard curve is applied.
Precision with commercial quality cpntrol sera of apolipoprotein
A-I: At a low concentration (0.48 g/l) our between-run CV is 5.6%
and at a high coneentration (1.88 g/l) the CV is 4.5%.
Turbidimetry (Orion/Kone)
In the turbidimetric immuno-assay of the Department of Epidemi-
ology we used the reagent kits of Orion Diagnostica (Espoo, Fin-
land) and the Kofie Specific Analyzer (Kone, Espoo, Finland).
The method is based on turbidimetric measurement at 340 nm of
immunoprecipitation, enhanced by polyethylene glycol. Diluted
antibody solution (150 ) is added to a 15-fold serum dilutipn (30
) with buffer solution supplied with the kit. The inereases in
absorbance are recorded at a fixed time*(30 minutes) after reagent
mixing. A lyophilized calibrätor is included in the kit and applied
äs a five-point Standard eurve.
According to the manufacturer, calibration values have been ob-
tained by direct comparison with reference materials provided by
CDC. Two other commercially available reference Standards
(Boehringer Mannheim, Mannheim, Germany and Immuno AG,
Vienna, Austria) and Precinorm L (Boehringer Mannheim, Ger-
many) served äs controls.
Method characteristics (Orion): The Department of Epidemiology
started serni-automated apolipoprotein analyses in 1988 äs part of
a population based survey (EPOZ study, (12)). In the second half
of 1988, they also participated in an international survey (10) and
five vials of lyophilized poolsera (high, medium, low) were ana-
lyzed in duplieate on five days by all participants. The results for
apolipoprotein A-I were respectively (overall rnean (n = 82), turbi-
dimetry mean (n = 23), our result): 1.04, 0.98 and 0.94; 0.86, 0.81
and 0.84; 0.43, 0.40 and 0.40 g/l. The average CV was 6.1%.
For apolipoprotein B the results were: 1.04, 0.94 and 0.79; 0.84,
0.80 and 0.71; 0.46, 0.45 and 0.40 g/l.
The average CV was 5.6%.
Results
tlie apolipoprotein determinations yielded a total of
58-59 complete data sets fromjäll three laboratories.
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The Dimension analyzer was arbitrarily designated äs
"x" and the Array and Orion/Kone methods äs "y" in
both comparisons appearing below. Orthogonal regres-
sion analyses (Deming & Morgan, (15)) and regression
caleulations according to Passing & Bablok (16) gave
the results listed in table 1.
We calculated reference ranges for apolipoprotein A-I
and B with data obtained by each of our three methods
äs the mean ± 2 SD's, since medians hardly differed
from the means, and we found the following ranges.
Apolipoprotein A-I reference ranges (g/l)
DuPont 0.80 - 1.56,
Beckman 0.76 - 1.60,
Orion/Kone 0.81 - 1.49.
Apolipoprotein B reference ranges (g/l)
DuPont 0.46 - 0.98,
Beckman 0.62 - 1.28,
Orion/Kone 0.53 - 1.11.
Tab. l Values from the regression equations y = ax + b of
method comparisons on apolipoprotein A-I and apolipoprotein B
assays. Concentration units g/l.







































































The assays were compared by performing orthogonal (according
to Deming & Morgan) äs well äs Passing .& Bablok regression
analyses, leading to equations y = ax + b; where a and b are the
slope and y-intercept respectively — given with their Standard devi-
ations Sa and Sb< - and r is the correlation coefficient.
Assay methods were (1) DuPont Dimension analyzer and (2) Beck-
man Array analyzer with -their reagent Systems and (3) Orion rea-
gents on a Kone analyzer.
Discussion
For 'the evaluation of paediatric patients receiving
growth hormone therapy, it was necessary to re-establish
reference ranges for apolipoprotein A-I and B.
The three cooperating laboratories involved in this study
use three different apolipoprotein assays. The measure-
ment of serum apolipoproteins is usually connected with
establishing coronary risk profiles and the need to stan-
dardize such measurements is well recognized. Studies
in the eighties revealed that commercial calibrator mate-
rials were not commutable for the various immuno-pre-
cipitation methods äs used by clinical laboratories (1).
This causes in part significant inter-method assay varia-
tions. To enhance the accuracy of routine methods, certi-
fied international reference serum had to be developed
which required a collaborative study of major manufac-
turers and leading research laboratories.
On the basis of (limited) Information available to us
from two of our manufacturers, we hoped to find reason-
ably comparable test results, although it may have been
too early to expect such results to dissipate into daily
practice. These manufacturers had participated in the
IFCC Standardization Project for Measurements of
Apolipoprotein A-I and B.
The outcome for apolipoprotein A-I was published in
1993 (9) and for apolipoprotein B more recently (11).
The confirmatory method comparison for apolipoprotein
A-I was performed in part 3 of the study after each sin-
gle method had been calibrated on previously checked
target values for the in-house materials. This check of
target values occurred after the materials were assayed
4 times in 2 runs per day on each of 5 different days
(n = 40) in parallel with the proposed WHO-IFCC ref-
erence material SP1-01. In order to confirm the outcome
of the Standardization of in-house Standards, 50 human
serum samples were analyzed in duplicate in 2 different
runs. The results demonstrate that comparable apolipo-
protein A-I results can be obtained by a variety of im-
munochemical methods through the use of certified ref-
erence materials. We would like to discuss this result in
more detail.
Indeed the success is reflected by an overall inter-assay
CV of less than 5% and by an average absolute bias of
no more than 2.8%. Still it is interesting to take a closer
look at some of the participants (9) since they seem to
deviate quite far from the ideal regression equation. Ta-
ble 3 in the paper in question (9) shows a few partici-
pants in the IFCC study with slopes deviating signifi-
cantly from 1.0. To estimate the effect of this on refer-
ence ranges, we calculated the effect upon a hypothe-
sized accurate reference ränge of 0.70—1.50 g/l. The
chosen four laboratory results from 1. c. (9) are:
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y = 0.79 x + 0.25,
y = 0.82 + 0.21,
y = l . löx - 0.21,
and y = 1.20 - 0.22.
An accurate reference ränge of 0.70-1.50 g/l, recalcul-




and 0.62 - 1.58 g/l.
The differences among these calculated reference ranges
are not small enough to be neglected and they arise in
well standardized centres.
Our own results do show intermethod differences of the
same order of magnitude. Our upper ranges for apolipo-
protein A-I vary from l .49 to l .60 g/l.
Although the examples above concern only 4 out of 29
methods for apolipoprotein A-I, we feel that 4/29 are no
rare exceptions and they underline the fact that the
transfer of accuracy to general clinical laboratories is no
easy matter.
For the standardization of apolipoprotein B, there now
is a WHO-IFCC International Reference Material avail-
able äs a well-stabilized liquid serum product: SP3-07.
Table 3 in the paper (11) shows to what extent unifor-
mity among methods was obtained. The 25 analytical
Systems show regression equations between
y = 0.83 + 0.15
and y = 1.14 - 0.13.
For these two cases, the above discussion on apolipo-
protein A-I applies äs well, in that a rnanufacturer rnust
not use these data äs the basis for produoing secondary
calibrators. Both examples fäll within the arbitrary cri-
teria for being considered standardized for apolipoprot-
ein B because the overäll imprecisjon is < 5% and over-
all bias is < 6%. Still, a low slope combined with a
positive y-intercept, or vice versa, a high slope com-
bined with a negative y-intefcept, although both lead to
the same average apolipoprotein values, result in very
different reference ranges.
Clearly these comparisons demonstrate that reference
ranges dififer too much to be interchangeable. We expect
that the manufacturers in the IFCC studies will re-adjust
their method calibrations to finally obtain slopes within
5% of unity and y-intercepts within 0. l g/l of zero. This
does not at all question the fact that great progress will
be made in harmonizing lipoprotein measurements when
using the International Reference Materials.
In paediatric laboratory medicine, there is a frequent
lack of reference values due to the enormous difficulties
in obtaining proper samples in high enough numbers
(17). This matter is a sübject for further study.
In conclusion, the comparability arnong pur three apoli-
poprotein A-I äs well äs among our three apolipoprotein
B methods is not good enough to pool the analytical
data nor to use common reference values.
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